Claus et al., demonstrated using fibrosarcoma, colon adenocarcinoma and melanoma tumour-bearing wild-type mice, that the CD27–CD70 interaction increased the frequency of regulatory T cells, reduced tumour-specific T-cell responses, increased angiogenesis, and promoted tumour growth (Claus et al. 2012). This evidence concerns the gene CD27 and melanoma.